The pilot implementation of the PN for primary cancer prevention that includes agencies working with professionals and all patients who can benefit from smoking cessation, physical activity, and diet interventions. CO-CAPTAIN will implement a large-scale pilot of primary cancer prevention in different health and care systems in Europe, informing the blueprint for policy transformation. Our objective is to identify and analyze potential facilitators and critical barriers for the PN for primary cancer prevention implementation process, outcomes, and future dissemination and exploitation strategies using a mixed-methods approach supported by the CFIR and RE-AIM conceptual frameworks. Special attention will be given to reducing the evidence-practice gap in health psychology and capturing the factors influencing behavioural change.

The effectiveness of the intervention and its impact on costs will  be assessed, grouped by the process for an intervention-based measurement of outcome values for individuals with mental ill-health and use precise and data-driven models of health outcomes. CO-CAPTAIN will provide the blueprint for transforming cancer prevention for all persons, integrating PN and delivering primary cancer prevention programs across health and care systems in the EU.


The Cancer Prevention at Work (CPW) project researches the cost-effectiveness and social acceptance of incorporating prevention of cancers associated with Helicobacter pyloriHepatitis C virus and Human Papillomavirus into ongoing primary occupational health surveillance programmes. The project involves workers and their families, policymakers, occupational health organizations, health authorities, companies and workers’ representatives, and cancer and patient organisations, among others, to identify the best strategies to increase the adherence of the population of workers in screening programs of infection-related cancers.


The research project ONCODIR will identify risk factors associated with colorectal cancer and will integrate multidisciplinary research methods and technologies (including health policy analytics, artificial intelligence and decision support theories) to deliver evidence-based and personalized recommendations on colorectal cancer prevention. ONCODIR is developing a platform based on artificial intelligence and privacy principles. It will provide recommendation services based on input from citizens, clinicians and policy-makers. The project will consider factors such as lifestyle, nutrition and economics.


PREVENT is a collaborative action to improve and upscale primary prevention of cancer by addressing childhood obesity. Through diligent implementation research and a comprehensive approach, this project aims to lay the foundation for a future where healthier lifestyles and brighter tomorrows await every child. The PREVENT project mission is rooted in epidemiological studies that have highlighted a clear link between obesity and increased risks of various types of cancer, including colon, endometrium, postmenopausal breast, and kidney cancer, among others.


4P-CAN’s mission is to understand barriers, whether legislative, socio-economic, commercial, or behavioural to the widespread adoption of cancer primary prevention measures across Central and Eastern Europe. By understanding barriers to policy implementation and individual adherence to healthy behaviours, 4P-CAN will improve primary prevention activities and reduce inequalities. With the collaboration of 17 organizations from 11 countries, including both EU and non-EU Balkan countries, as well as Western EU countries, 4P-CAN is dedicated to achieving these goals and fostering a healthier future.

The PIECES project aims to adapt and implement existing evidence-based programmes to improve implementation outcomes and by that, improve the reach and effectiveness of primary prevention programmes in real-world settings. It will address a wide range of risk factors and focus on the specific behaviour change mechanisms that promote healthy behaviours associated with a reduction of cancer incidence among the European Union (EU) population and beyond.